Residual Solvents Testing: GC Methods, USP <467>, and Limits
Representative Infinita Engineering Visual explaining the four-step workflow for Residual Solvents Testing.What Is Residual Solvents Testing?
Residual solvents testing quantifies volatile organic compounds left behind in a pharmaceutical drug substance, excipient, or drug product following manufacturing. USP General Chapter <467> defines the classification, risk assessment, and analytical procedures — and applies to all new and existing drug products, unlike ICH Q3C, which applies only to new products.
Solvent Classification
- Class 1: known or suspected human carcinogens — should be avoided entirely wherever possible
- Class 2: non-carcinogenic but toxic — strictly limited to specific concentration thresholds
- Class 3: lower toxicity, permitted up to 5000 ppm under normal use conditions
Test Procedure
Class 1 and Class 2 solvents are determined by static headspace gas chromatography with flame ionization detection (HS-GC-FID). Class 3 solvents have more analytical flexibility but are often included in the same headspace run.
- Prepare the sample and reference/system suitability solutions per USP <467> Procedure A or B
- Equilibrate sample vials in the headspace sampler at the specified temperature (commonly around 80C) for the specified hold time
- Inject equal headspace volumes of standard, system suitability, and sample solutions into the GC
- Record chromatograms and evaluate system suitability criteria (signal-to-noise ratios and peak resolution requirements)
- Compare sample peak responses against the standard to determine pass/fail (limit test) or quantify concentration (quantitative test)
System Suitability Requirements
USP <467> specifies minimum signal-to-noise ratios (e.g., NLT 5 for benzene in the Class 1 standard) and minimum resolution between closely eluting peaks (e.g., NLT 1.0 between methylisobutylketone and cis-dichloroethene) before sample results can be considered valid.
Industry Specifications Referencing Residual Solvents Testing
- USP <467>: primary US pharmacopeial standard
- ICH Q3C: harmonized guideline, applies to new drug products
- EP 2.4.24: closely aligned European Pharmacopoeia equivalent
Conclusion
USP <467> testing is a mandatory gate for FDA drug submissions (ANDA, NDA, IND), and because the standard specifies exact system suitability thresholds, a lab’s chromatographic setup has to demonstrate compliance on every run — not just produce a number that looks reasonable.
What are residual solvents? Residual solvents are volatile organic chemicals used or produced during the manufacture of pharmaceutical ingredients, excipients, and finished products. They may remain in trace amounts after processing or drying.
Why is residual solvent testing important? Residual solvent testing confirms that potentially harmful solvents remain within safety-based limits. It supports patient safety, product quality, manufacturing control, and regulatory compliance.
What is USP <467>? USP General Chapter <467> provides requirements for identifying, controlling, and testing residual solvents in pharmaceutical and dietary supplement products. It aligns its safety principles with the ICH Q3C guideline.
How are residual solvents classified? Class 1 solvents should generally be avoided because of unacceptable toxicity. Class 2 solvents must be limited, while Class 3 solvents have lower toxic potential and are preferred when practical.
Which analytical method is commonly used? Gas chromatography is the most widely used method because it can separate, identify, and quantify volatile solvents. Laboratories may use compendial procedures or validated alternative GC methods suitable for the product.
Other Categories
